How much does Advent Life Sciences typically invest?

Advent Life Sciences states a typical cheque of €1M – €30M.

Which stages does Advent Life Sciences invest in?

Advent Life Sciences invests at Seed, Series A and Series B.

Where is Advent Life Sciences based?

Advent Life Sciences is headquartered in London, United Kingdom.

Investor directory

Advent Life Sciences

VC fundLondon, United Kingdomadventls.com LinkedIn

Advent Life Sciences' edge comes from its deep industry expertise and a collaborative partnership model with portfolio companies.

What they invest in

Stages

Seed Series A Series B

Sectors

Biotech & Pharma HealthTech

Geographies

UKEuropeUSA

The facts

Typical cheque: €1M – €30M
Headquarters: London, United Kingdom
Founded: 2006

Portfolio companies

Cyted Epitopea Highlight Therapeutics

More portfolio companies

Centessa PharmaceuticalsBeacon TherapeuticsIterum Therapeutics (OTCM: ITRMF)Nalu MedicalAraviveAcutus Medical (OTCM: AFIB)F2GAura Biosciences (NAS: AURA)GlycomineProximieKaNDy TherapeuticsAviadoBioMoximedAxonicsArrakis TherapeuticsArgá MedtechNeRRe TherapeuticsArtax BiopharmaPIC TherapeuticsCyted HealthVestagenZikani TherapeuticsWondr MedicalCurve Therapeutics

and 8 more

Questions founders ask

How much does Advent Life Sciences typically invest?: Advent Life Sciences states a typical cheque of €1M – €30M.
Which stages does Advent Life Sciences invest in?: Advent Life Sciences invests at Seed, Series A and Series B.
Where is Advent Life Sciences based?: Advent Life Sciences is headquartered in London, United Kingdom.

Does Advent Life Sciences fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Advent Life Sciences? Tell us what to correct and we will update it — or ask us to remove the entry.